State Of Alaska, Department Of Revenue Pfizer Inc Transaction History

State Of Alaska, Department Of Revenue

$8.78 Billion
Q1 2024

A detailed history of State Of Alaska, Department Of Revenue transactions in Pfizer Inc stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 861,671 shares of PFE stock, worth $24.1 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

861,671

Previous 895,381 3.76%

Holding current value

$24.1 Million

Previous $25.8 Million 7.24%

% of portfolio

0.27%

Previous 0.31%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$25.89 - $29.73 $872,751 - $1 Million	-33,710 Reduced 3.76%	861,671 $23.9 Million
Q4 2023 Jan 19, 2024	SELL	$26.13 - $33.94 $1.48 Million - $1.92 Million	-56,605 Reduced 5.95%	895,381 $25.8 Million
Q3 2023 Oct 16, 2023	SELL	$32.09 - $37.51 $847,176 - $990,264	-26,400 Reduced 2.7%	951,986 $31.6 Million
Q2 2023 Jul 24, 2023	SELL	$36.12 - $41.79 $5.08 Million - $5.88 Million	-140,711 Reduced 12.57%	978,386 $35.9 Million
Q1 2023 Apr 17, 2023	SELL	$39.39 - $51.28 $375,859 - $489,313	-9,542 Reduced 0.85%	1,119,097 $45.7 Million

Q4 2022 Jan 11, 2023	BUY	$41.75 - $54.5 $285,778 - $373,052	6,845 Added 0.61%	1,128,639 $57.8 Million
Q3 2022 Oct 20, 2022	SELL	$43.76 - $53.42 $1.89 Million - $2.31 Million	-43,171 Reduced 3.71%	1,121,794 $49.1 Million
Q2 2022 Jul 08, 2022	BUY	$46.53 - $55.17 $5 Million - $5.93 Million	107,476 Added 10.16%	1,164,965 $61.1 Million
Q1 2022 Apr 14, 2022	SELL	$45.75 - $56.69 $1.19 Million - $1.47 Million	-25,964 Reduced 2.4%	1,057,489 $54.7 Million
Q4 2021 Jan 12, 2022	BUY	$41.32 - $61.25 $1.16 Million - $1.72 Million	28,101 Added 2.66%	1,083,453 $64 Million
Q3 2021 Oct 07, 2021	SELL	$39.25 - $50.42 $628,196 - $806,972	-16,005 Reduced 1.49%	1,055,352 $45.4 Million
Q2 2021 Jul 12, 2021	BUY	$35.91 - $40.68 $848,158 - $960,820	23,619 Added 2.25%	1,071,357 $42 Million
Q1 2021 Apr 09, 2021	SELL	$33.49 - $37.77 $1.47 Million - $1.66 Million	-43,951 Reduced 4.03%	1,047,738 $38 Million
Q4 2020 Jan 08, 2021	SELL	$33.47 - $42.56 $2.02 Million - $2.57 Million	-60,499 Reduced 5.25%	1,091,689 $40.2 Million
Q3 2020 Oct 05, 2020	BUY	$31.75 - $37.25 $696,118 - $816,706	21,925 Added 1.94%	1,152,188 $42.3 Million
Q2 2020 Jul 06, 2020	BUY	$30.12 - $36.54 $2.57 Million - $3.11 Million	85,235 Added 8.16%	1,130,263 $37 Million
Q1 2020 Apr 06, 2020	BUY	$27.03 - $38.62 $1.47 Million - $2.1 Million	54,336 Added 5.48%	1,045,028 $34.1 Million
Q4 2019 Jan 07, 2020	SELL	$32.92 - $37.36 $4.56 Million - $5.18 Million	-138,566 Reduced 12.27%	990,692 $38.8 Million
Q3 2019 Oct 02, 2019	SELL	$32.49 - $42.13 $7.76 Million - $10.1 Million	-238,745 Reduced 17.45%	1,129,258 $40.6 Million
Q2 2019 Jul 23, 2019	BUY	$36.98 - $41.52 $392,616 - $440,817	10,617 Added 0.78%	1,368,003 $59.3 Million
Q1 2019 Apr 09, 2019	SELL	$37.5 - $41.2 $1.92 Million - $2.11 Million	-51,276 Reduced 3.64%	1,357,386 $57.6 Million
Q4 2018 Jan 10, 2019	SELL	$38.47 - $43.86 $70,707 - $80,614	-1,838 Reduced 0.13%	1,408,662 $61.5 Million
Q3 2018 Oct 09, 2018	SELL	$34.47 - $41.81 $2.69 Million - $3.27 Million	-78,115 Reduced 5.25%	1,410,500 $62.2 Million
Q2 2018 Jul 10, 2018	BUY	$32.98 - $35.16 $5.49 Million - $5.86 Million	166,546 Added 12.6%	1,488,615 $54 Million
Q1 2018 Apr 19, 2018	BUY	$31.91 - $37.02 $2.67 Million - $3.1 Million	83,650 Added 6.75%	1,322,069 $46.9 Million
Q4 2017 Jan 19, 2018	BUY	$33.26 - $35.29 $17 Million - $18.1 Million	512,311 Added 70.56%	1,238,419 $44.9 Million
Q3 2017 Oct 16, 2017	BUY	$31.0 - $34.15 $22.5 Million - $24.8 Million	726,108	726,108 $25.9 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.

Account

State Of Alaska, Department Of Revenue Pfizer Inc Transaction History